文献
J-GLOBAL ID:200902283384610157
整理番号:09A0389165
がん治療の新たな手法としてのNEDD8活性化酵素阻害薬
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
著者 (35件):
SOUCY Teresa A.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
SMITH Peter G.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
MILHOLLEN Michael A.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
BERGER Allison J.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
GAVIN James M.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
ADHIKARI Sharmila
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
BROWNELL James E.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
BURKE Kristine E.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
CARDIN David P.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
CRITCHLEY Stephen
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
CULLIS Courtney A.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
DOUCETTE Amanda
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
GARNSEY James J.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
GAULIN Jeffrey L.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
GERSHMAN Rachel E.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
LUBLINSKY Anna R.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
MCDONALD Alice
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
MIZUTANI Hirotake
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
NARAYANAN Usha
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
OLHAVA Edward J.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
PELUSO Stephane
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
REZAEI Mansoureh
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
SINTCHAK Michael D.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
TALREJA Tina
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
THOMAS Michael P.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
TRAORE Tary
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
VYSKOCIL Stepan
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
WEATHERHEAD Gabriel S.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
YU Jie
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
ZHANG Julie
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
DICK Lawrence R.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
CLAIBORNE Christopher F.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
ROLFE Mark
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
BOLEN Joseph B.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
,
LANGSTON Steven P.
(Millennium Pharmaceuticals, Inc., Massachusetts, USA)
資料名:
Nature (London)
(Nature (London))
巻:
458
号:
7239
ページ:
732-736
発行年:
2009年04月09日
JST資料番号:
D0193B
ISSN:
0028-0836
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)